Ensuring the Least Restrictive Medication

June 27, 2025

A Guide for Carers Using the Maudsley Deprescribing Guidelines

The overuse of psychotropic drugs is a significant concern in healthcare, aged care, and disability services. This issue has been highlighted during several Disability Royal Commission hearings, bringing to light the need for more responsible prescribing practices and better support for individuals affected by these medications.


On Wednesday, 12 March 2025, the Striking the Balance forum featured keynote speakers Dr. Mark Horowitz, an expert in psychotropic drugs and author of the Maudsley Deprescribing Guidelines, and Professor Julian Trollor, Director of the National Centre of Excellence in Intellectual Disability Health. These experts shared valuable insights into the challenges and solutions related to the overuse of psychotropic drugs.

Deprescribing: Is the process of tapering or stopping medications that may no longer be necessary or beneficial. It aims to minimise medication burden and reduce the risk of side effects and dependency

Dr. Horowitz emphasised the importance of deprescribing guidelines to help healthcare providers reduce the reliance on psychotropic medications. His Maudsley Deprescribing Guidelines offer a structured approach to safely tapering off these drugs, ensuring that patients receive appropriate care without unnecessary medication.

Professor Trollor highlighted the need for comprehensive health assessments and personalised care plans for individuals with intellectual disabilities. He stressed that psychotropic drugs should not be the first line of treatment and that alternative therapies and supports should be considered to address behavioural and mental health issues.


Steps for Carers to Ensure Least Restrictive Medication


  1. Comprehensive Assessment:
    Begin with a thorough assessment of your loved one's current medications, health status, and behavioural needs. Collaborate with healthcare professionals to understand the necessity of each medication and identify potential candidates for deprescribing.

  2. Educate Yourself and Your Loved One:
    Familiarise yourself with the Maudsley Deprescribing Guidelines and educate your loved one about the benefits and process of deprescribing. Understanding the guidelines can empower both of you to make informed decisions about medication management.

  3. Collaborate with Healthcare Providers:
    Work closely with doctors, pharmacists, and other healthcare providers to develop a personalised deprescribing plan. Ensure that the plan includes gradual tapering schedules, monitoring for withdrawal symptoms, and strategies for managing any challenges that may arise.
     
  4. Monitor and Support:
    Regularly monitor your loved one's progress during the deprescribing process. Be vigilant for any signs of withdrawal or changes in behaviour. Provide emotional support and reassurance to help them cope with the transition.
     
  5. Use Non-Pharmacological Interventions:
    Explore non-pharmacological interventions that can support your loved one's health and well-being. This may include behavioural therapies, lifestyle changes, and other supportive measures that can reduce the need for medication.

  6. Advocate for Your Loved One:
    Advocate for your loved one's right to receive the least restrictive medication. Ensure that healthcare providers consider their preferences and needs when making decisions about medication management.
     

The overuse of psychotropic drugs in healthcare, aged care, and disability services is a pressing issue that requires immediate attention. By adopting deprescribing guidelines and personalised care plans, carers and healthcare providers can work together to ensure that individuals receive the most appropriate and effective care.

News & Insights

Check Our Latest Resources

May 8, 2026
Pathological Demand Avoidance, sometimes reframed as Persistent Drive for Autonomy, is a profile that many people within the autism community recognise. Although PDA is not a formal diagnosis in current diagnostic manuals, many clinicians and autistic individuals describe it as a meaningful way of understanding patterns of demand avoidance that stem from anxiety, uncertainty, and a strong need for autonomy. PDA is often misunderstood, which can lead to unhelpful assumptions or the belief that individuals are being deliberately oppositional. A neuroaffirming perspective helps us understand PDA as a valid part of neurodiversity. It shifts the focus away from control and compliance and towards emotional safety, autonomy, and collaboration. What Is PDA PDA describes an anxiety driven need to avoid everyday demands, even when the person wants to participate. These demands may feel overwhelming or threatening because they involve expectation, uncertainty, or a loss of control. Common characteristics described in the PDA profile include: A strong need to avoid demands, sometimes using strategies like humour, negotiation, distraction, or retreat A style of communication that may appear socially confident at first but does not always match deeper social understanding Rapid changes in mood, often linked to pressure or anxiety A comfort with imaginative play or adopting roles, which can help manage stressful situations These behaviours are not acts of defiance. They are protective responses from a nervous system that experiences demands as a source of intense stress. Is PDA a Diagnosis PDA is not recognised as an independent diagnosis in the DSM or ICD. Many professionals view it as a profile within autism, while others see it as a pattern that can appear in a range of neurodivergent presentations. There is ongoing debate, and research is still developing. Despite this, PDA is increasingly recognised in multidisciplinary autism assessments, particularly in the United Kingdom. Families and practitioners often find the PDA framework useful because it offers a way to understand demand avoidance compassionately and practically. Why Understanding PDA Matters People with PDA are often described as oppositional or non compliant, when in reality their behaviour reflects: high anxiety sensitivity to expectations a need for predictability a strong drive for autonomy and control When misunderstood, young people and adults with PDA may experience unnecessary conflict, shame, or burnout. A more informed perspective encourages compassion and supportive strategies instead of pressure or discipline. Neuroaffirming Approaches to Supporting PDA Supporting individuals with PDA is most effective when the focus is on reducing pressure, building trust, and supporting autonomy. Reduce Demands Where Possible Small changes can make a big difference. Indirect language, gentle invitations, choices, humour, and collaborative problem solving reduce pressure and help the person stay regulated. Traditional reward systems or consequences often increase anxiety and are less effective. Increase Autonomy A sense of control helps reduce distress. Offering choices, negotiating tasks, and allowing flexibility helps build cooperation and reduces overwhelm. Support Emotional Safety PDA is closely linked to anxiety and uncertainty. Predictable routines, sensory supports, clear expectations, and a calm supportive presence can help reduce stress. Connection and co regulation often pave the way for engagement. Work With Strengths Creativity, quick thinking, focused interests, humour, and imaginative play are often strong tools for learning and communication. Using these strengths helps build confidence and makes participation feel safe. A Neurodiversity Affirming Perspective Some clinicians and advocates argue that the term PDA can be pathologising, because it suggests something is wrong with a person’s natural need for autonomy. Alternative terms like Persistent Drive for Autonomy reflect a more respectful understanding of how the individual experiences the world. This perspective views PDA as a difference rather than a problem and focuses on approaches that prioritise dignity, safety, and empowerment. Summary PDA is a meaningful way to understand how some autistic and neurodivergent individuals respond to demands. It is not about refusing for the sake of it. It is about managing anxiety, protecting autonomy, and navigating a world that often feels unpredictable or overwhelming. Awareness and compassionate understanding help families, educators, support workers, and clinicians create environments where individuals with PDA can feel heard, respected, and supported to thrive. References PDA Society. Identification and Assessment of a PDA Profile. Gerlach, J. (2024). Five Things to Know About Pathological Demand Avoidance. Psychology Today. Naseef, R., Shore, S. (2025). Reframing Pathological Demand Avoidance. Autism Spectrum News. Science Insights (2026). What Is a PDA Diagnosis. AuDHD Psychiatry UK (2026). What Is PDA Autism. PDA North America (2025). Understanding and Supporting PDA.
May 8, 2026
Supporting children to feel calm, confident, and successful in busy community environments
May 8, 2026
Supporting your child while remembering that your wellbeing matters too.